SCLXW
MaterialsScilex Holding Company - Warrants (10/11/2027)
$0.20-0.01 (-6.43%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving SCLXW Today?
No stock-specific AI insight has been generated for SCLXW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.04$0.65
$0.20
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume2K
Avg Volume (10D)—
Shares Outstanding—
SCLXW News
20 articles- Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings LimitedYahoo Finance·May 5, 2026
- Wade Defendants Dispute Complaint and Statement by Scilex Holding CompanyYahoo Finance·May 5, 2026
- Datavault AI Signs Binding Term Sheet for $120 Million Cash Contribution From ScilexYahoo Finance·Apr 27, 2026
- Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug InformationYahoo Finance·Nov 4, 2025
- Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AIYahoo Finance·Nov 4, 2025
- Scilex Holding Company (NASDAQ:SCLX) Is Expected To Breakeven In The Near FutureYahoo Finance·Oct 28, 2025
- Datavault AI Turned Its Balance Sheet Into a Growth Engine; Proving Treasury Innovation Can Generate Millions (NASDAQ: DVLT)Yahoo Finance·Oct 6, 2025
- Datavault AI Converts $13.3 Million in Convertible Debt, Strengthens Balance SheetYahoo Finance·Oct 2, 2025
- Datavault AI (DVLT) Signs MOU With Korea Aerospace University to Advance Digital Credentialing, Aerospace InnovationYahoo Finance·Oct 2, 2025
- Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant RepurchaseYahoo Finance·Oct 1, 2025
- Datavault AI Goes From Under the Radar to Fully Armed with Capital, Credibility, and CommitmentYahoo Finance·Sep 29, 2025
- Datavault AI's $150M Vault Just Opened to Expedite "Proof as an Asset" Market (NASDAQ:DVLT)Yahoo Finance·Sep 29, 2025
- With $150 Million Banked, Datavault AI is Making "Proof" the Next Billion-Dollar Asset Class (NASDAQ:DVLT)Yahoo Finance·Sep 29, 2025
- This Penny Stock Is Surging on Supercomputer and Bitcoin Plans. Should You Buy It Now?Barchart·Sep 26, 2025
- Datavault AI (DVLT) Touches $1 Level Anew After 4 Months on New $150-Million InvestmentYahoo Finance·Sep 26, 2025
- Ignored No More: Datavault AI Turns Heads After Getting $150 Million From Scilex Holding (NASDAQ:DVLT)Yahoo Finance·Sep 25, 2025
- Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 2025Yahoo Finance·Sep 23, 2025
- Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business CombinationYahoo Finance·Sep 22, 2025
- Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business CombinationYahoo Finance·Sep 4, 2025
- Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.00 per share and Jaisim Shah, Scilex’s CEO and President, Will be Dedicated to Semnur on a Full Time Basis to Rapidly Advance SP-102 to Regulatory Approval and Commercialization for the Treatment of Lumbosacral Radicular Pain (LRP)/SciaticaYahoo Finance·Aug 21, 2025
All 20 articles loaded
Price Data
Open$0.18
Previous Close$0.21
Day High$0.21
Day Low$0.18
52 Week High$0.65
52 Week Low$0.04
52-Week Range
$0.04$0.65
$0.20
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume2K
Avg Volume (10D)—
Shares Outstanding—
About Scilex Holding Company - Warrants (10/11/2027)
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.
MaterialsBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CIK—
Composite FIGI—
Share Class FIGI—